Bacterin CEO Dan Goldberger will present at the Canaccord Genuity Musculoskeletal Conference in Las Vegas on March 24.
Bacterin develops, manufactures and markets biologics products to domestic and international markets, which can be used for a number of applications, including spinal fusions and back pain relief.
More articles on devices:
Smith & Nephew shares lost 7.14% last week — 5 key updates
Stryker shares drop 4.94% in 7 days: 5 things to know
Minimus Spine receives U.S. patent — 5 things to know